Long-Term Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks in Patients with Plaque Psoriasis: Pooled 128-Week Data from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin [Internet]. 2019 Nov. 9 [cited 2025 Apr. 19];3:S36. Available from: https://skin.dermsquared.com/skin/article/view/763